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Abstract
Direct lithiation of 1-(2-tetrahydrofuryl)-5-fluorouracil (Ftorafur) has been investigated. The treatment
of ftorafur with lithium diisopropylamide (LDA) at -70C in ether-hexane, followed by the reaction
with various electrophiles afforded the corresponding 6-substituted silicon, germanium and tin
derivatives of ftorafur. The results of biological investigation indicate the ability of germanium-modi-
fied nucleoside analogues to interfere with transcription and replication processes.
Introduction
The chemistry of nucleosides is a rapidly growing area of research. Nowadays the synthetic
analogues of nucleosides are used as antimetabolites in biochemistry and medicine. Examples are
antiviral agents such as the nucleoside analogues 3’-azidothymidine possessing anti-HIV activity
and acycloguanosine with antiherpes activity, the antitumor agents Ftorafur and 5-fluorouridine,
and "antisense-RNA" and "antisense-DNA" used as gene blockers.
Recently the lithiation of uracil acyclonucleosides was employed to obtain 6-substituted deriva-
tives (1-3). We have investigated the lithiation of another type of nucleoside analogues N-1
tetrahydrofuryl derivatives (4,5). An antitumor agent 1-(2-tetrahydrofuryl)-5-fluorouracil (Ftorafur) (6)
has been chosen for the introduction of organometallic substituent to C-6 position of uracil.
Experimental
Synthesis of 1-(2-tetrahydrofuryl)-5-fluoro-6-trimethylgermyluracil (111)
n-Butyllithium (58.2 ml, 1.25 N in hexane) was added dropwise to a solution of freshly distilled
i-Pr2NH (7.34 g, 0.073 mol) cooled to -10C. After the addition of butyllithium the reaction mixture
was stirred for 30 min then cooled to-78C and dissolved in 100 ml of THF. After cooling a solution
of ftorafur (3.4 g, 0.017 mol) in 70 ml ofTHF was added dropwise. The mixture was stirred for I h at
-78C, and a solution of trimethylchlorogermane (11.25 g, 0.073 mol) in 10 ml of THF was added
dropwise at temperature kept below-70C. The mixture was allowed to stand overnight. The
solvents were removed in vacuo. The residue was dissolved in the saturated ammonium chloride
solution in water and neutralized to pH 7 with the diluted HCI. After 1 h the desired product was
filtered off (4.15 g, 77%). Compound III was recrystallized from EtOH, m.p. 132-134C, on TLC it
gave one spot (CHCI3 EtOH, 5:1, v/v, Rf 0.70).
The compounds I, II, IV and V were prepared in the similar manner. Yields, melting points and
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Table 1. Analytical data of 6-substituted 1-(2-tetrahydrofuryl)-5-fluorouracils
Compound Yield (%) M.p. (C) Formula Analytical data (%) (found/calc.)
N C H
10.77 48.60 6.01
2 162-3 C11H17FN203Si 10.29 48.5" .2
8.94 53.85 7.39 II 62 93-4 C14H23FN203Si 8.91 53.48 7.37
8.72 41.90 5.30 III 77 132-4 C H7FN203Ge 8.84 41.70 5.41
7.77 47.01 6.44 IV 84 82-3 C14H23FN203Ge 7180 46185 6.46
7.38 36.46 4.41 V 19 151-2 C11H17FN203Sn 7.72 3’6.40 ’172
H NMR data were consistent with the structure of compounds I-IV
Crystallographic Study
The crystals of compounds and III for X-ray measurements were grown from ethanol solution. The
reflection intensities were collected on a Syntex-P2 single-crystal diffractometer using graphite-
monochromated Mo-K radiation ( 0.71069 A). The cell constants were obtained from a
least-squares refinement on the setting angles of 20 reflections.
Crystal data: Compound C1H17FN203Si, M 272.3, monoclinic, space group P2/c,
a= 7.981(2), b 11.067(3), c= 16.519(4)A,,8 115.77(2), V 1313.9(7)A3, Z= 4, F(O00)= 536,
Dx 1.30 g/cm3,/(MoK) 1.1 cm- Compound III CH17FN203Ge, M 316.8, monoclinic, space group P2/c, a 8.000(1),
b 11.1261(2), c 16.598(3) ,,, ,8 115.82(1), V 1329.9(4) ,.3, Z 4, F(O00) 608, Dx 1.50
g/cm3,/(MoK) 13.0 cm-.
The data were collected at room temperature from a well-shaped colorless crystals with the /20
scan technique up to 20max 40 for compound and 20max 55 for II1. No absorption
correction was applied at measurement stage.
1351 reflections for and 3070 reflections for III were collected, of which 958 and 2497 reflections
were unique and found to have > 2(.
The structures were solved by a direct method using program SHELXS (7). The non-hydrogen
atoms were found in a E-map. Initially, the positional parameters and isotropic temperature factors
of all non-hydrogen atoms were refined by full-matrix least-squares procedure. At this stage an
empirical absorption correction for compound III (program DIFABS) was performed (s).
The positions of hydrogen atoms were geometrically generated assuming the appropriate sp2- or
sp3-hybridization for the corresponding atoms. Nonhydrogen atoms were refined in the anisotropic
but hydrogens in the isotropic approximations. The final reliability factor R with unit weights was
0.0591 for compound and 0.0440 for compound II1. The highest peak in the final difference map
was 0.23 e/A3 and 0.36 e/A3 for compounds and III, respectively.
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Table 2. Bond distances () of compounds and III with e.s.d, values in parentheses
Bonds III
M Si M Ge
Bonds
M=Si
III
M=Ge
C(6)--M 1.951 (10) 2.011 (5) C(6)--N(1) 1.400 (9) 1.407 (5)
C(7)--M 1.842 (11) 1.935 (7) C(I’)--N(1) 1.475 (12) 1.478 (6)
C(8)--M 1.861 (14) 1.936 (8) C(2)--N(3) 1.368 (13) 1.370 (7)
C(9)--M 1.829 (11) 1.926 (5) C(4)--N(3) 1.362 (11) 1.372 (6)
C(5)--F 1.330 (10) 1.355 (5) C(5)--C(4) 1.453 (15) 1.446 (8)
C(1’)--0(1’) 1.399 (11) 1.412 (6) C(6)--C(5) 1.330 (13) 1.332 (7)
C(4’)--0(1’) 1.412 (12) 1.417 (7) C(2’)--C(1’) 1.492 (12) 1.516 (6)
C(2)--0(2) 1.213 (11) 1.215 (5) C(3’)--C(2’) 1.516 (19) 1.520 (11)
C(4)--0(4) 1.223 (13) 1.221 (7) C(4’)--C(3’) 1.492 (16) 1.490 (10)
C(2)--N(1) 1.397 (13) 1.386 (7)
Table 3. Bond angles (deg.) of compounds and III
Bond angles
M=Si
III
M=Ge
Bond angles
M=Si
III
M=Ge
M--C(6)--N(1) 122.6 (6) 123.2 (4) O(2)--C(2)--N(3) 123.1 (9) 121.3 (5)
M--C(6)--C(5) 120.0 (6) 120.1 (3) 0(4)--C(4)--N(3) 114.3 (10) 122.7 (5)
C(6)--M--C(7) 109.9 (5) 109.8 (3) 0(4)--C(4)--C(5) 125.5 (8) 126.2 (4)
C(6)--M--C(8) 111.5 (5) 111.6 (3) N(1)--C(2)--N (3) 114.3 (8) 115.8 (4)
C(6)--M--C(9) 106.5 (5) 105.8 (3) C(2)--N(1)--C(6) 122.6 (7) 122.1 (4)
C(7)--M--C(8) 105.8 (6) 106.6 (3) C(2)--N(1)--C(1’) 115.2 (7) 117.6 (3)
C(7)--M--C(9) 110.8 (6) 111.6 (3) N(1)--C(6)--C(5) 117.5 (8) 116.6 (4)
C(8)--M--C(9) 112.4 (6) 111.5 (3) C(6)--N(1)--C(1’) 122.3 (8) 120.3 (4)
F--C(5)--C(4) 113.6 (8) 113.6 (4) N(1)--C(1’)--C(2’) 118.6 (10) 116.2 (4)
F--C(5)--C(6) 121.7 (9) 120.3 (5) C(2)--N(3)--C(4) 128.7(10) 127.6 (6)
0(1’)--C(1’)--N(1) 111.4 (7) 110.1 (3) N(3)--C(4)--C(5) 111.7 (9) 111.2 (4)
0(1’)--C(1’)--C(2’) 108.8 (8) 108.2 (4) C(4)--C(5)--C(6) 124.7 (8) 126.2 (4)
C(1")--0(1’)--C(4’) 109.5 (7) 109.8 (4) C(1’)--C(2’)--C(3’) 102.6 (9) 101.9 (5)
0(1’)--C(4’)--C(3’) 104.6 (9) 104.8 (6) C(2’)--C(3’)--C(4’) 103.4 (10) 104.1 (6)
0(2)--C(2)--N(1) 122.6 (9) 122.9 (5)
The intramolecular bond distances for both structures are reported in Table 2, the bond angles in
Table 3, selected torsion angles in Table 4.
The final fractional coordinates and equivalent isotropic temperature factors (calculated from
refined anisotropic thermal parameters as Beq 82Du
1/3, were Du is the determinant of the Uij
matrix) with their esd’s in parentheses are listed in Tables 5 and 6.
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Table 4. Selective torsion angles (deg.) with e.s.d.
in parentheses
Torsion angles III
M Si M Ge
N(1)--C(1 ’)--O(1 ’)--C(4’)
c(3’)--c(2’)--c(- ’)--o(. ’)
C(2’)--C (1 ’)--O(1 ’)--C (4’)
C(3’)--C(4’)--O(1 ’)--C(1 ’)
C(4’)--C(3’)--C(2’)--C(1 ’)
0(1 ’)----C(4’)--C(3’)--C (2’)
C(3’)---C(2’)--C(1 ’)--N(1)
O(2)--C(2)--N(1)---C(6)
N(3)--C(2)--N(1)--C(6)
M--C(6)--N(1)--C(2)
C(5)--C(6)--N(1)--C(2)
M--C(6)--N(1)--C(1 ’)
C(5)--C(6)--N(1)--C(1 ’)
O(1 ’)--C (1 ’)--N(1)--C(2)
C(2’)--C(1 ’)--N(1)--C(2)
0(1 ’)--C(1 ’)--N(1)--C(6)
C(2’)--C(1 ’)--N(1)--C(6)
N(1)--C(2)--N(3)--C(4)
C(5)--C(4)--N(3)--C(2)
C(6)--C(5)--C(4)--N (3)
N(1)--C(6)--C(5)--C(4)
-123.5 (10) -121.3 (5)
12.3 (14) 14.3 (7)
9.0 (13) 6.7 (7)
-2&9 (5) -25.5 (9)
-27.5 (15) -28.8 (8)
33.6 (15) 33.8 (9)
140.9 (11) 138.8 (6)
172.0 (7) 172.8 (4)
-7.7 (10) -8.0 (5)
-173.1 (6) -173.0 (3)
6.8 (10) 6.6 (5)
5.8 (9) 5.8 (4)
-174.3 (7) -174.6 (3)
73.2 (9) 70.8 (5)
-54.2 (11) -52.7 (5)
-105.8 (9) 108.0 (5)
126.8 (10) 128.5 (4)
2.8 (12) 3.9 (6)
2.7 (11) 1.3 (6)
-3.9 (11) -3.0 (6)
-0.6 (11) -0.7 (6)
Biological Study
Macacus rhesus kidney fibroblast cells (FRhK) were cultivated in Eagle’s medium supplemented
with 30% lactalbumine hydrolysate, 10% bovine serum, 1% HEPES and 2% gentamycin. Ethanol-
diluted compounds were added to the incubation medium. The compound concentration was
adjusted to 150 mM, solvent concentration to 0.7%. The control sample was incubated with pure
ethanol. 3H-Uridine (5/Ci/ml, 30 min) or 3H-thymidine (5/Ci/ml, 60 min) incorporation effectivity
was measured to evaluate the intensity of either RNA or DNA biosynthesis. RNA was extracted with
LiCI-urea (9), DNA was purified by salting out procedure (o). Nucleic acid concentration was
measured spectrophotometrically, samples were hydrolyzed in 1 M HCI (80C, 15 min). Radioactiv-
ity was measured on the scintillation counter. Measurements were conducted in triplicate. Statistical
analysis was carried out by Student’s test. Results are presented as mean +_. SEM.
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Table 5. Fractional coordinates (x 104) for nonhydrogen atoms
in compound
Atom x
Si 4344 (3) 2136 (2) 5968 (1) 3.48 (7)
F 5012 (8) 1302 (5) 4369 (3) 5.76 (25)
0(1’) 6541 (S) 5413 (5) 6581 (4) 4.19 (23)
0(2) 9192 (8) 5171 (6) 5788 (4) 4.09 (25)
0(4) 7377 (8) 2148 (6) 3725 (4) 4.97 (27)
N(1) 7235 (8) 3727 (6) 5890 (4) 2.93 (24)
N(3) 8262 (11) 3639 (7) 4773 (5) 3.28 (41)
C(2) 8306 (11) 4250 (9) 5502 (5) 3.24 (43)
C(4) 7270 (11) 2633 (8) 4366 (6) 3.85 (26)
C(5) 6081 (11) 2243 (8) 4778 (5) 3.94 (28)
C(6) 6037 (10) 2752 (7) 5498 (5) 3.35 (23)
C(7) 2362 (15) 1367 (14) 5067 (8) 5.54 (44)
C(8) 3320 (16) 3383 (10) 6363 (9) 4.64 (39)
C(9) 5690 (16) 1079 (11) 6868 (8) 4.51 (43)
C(1’) 7432 (13) 4290 (9) 6736 (6) 3.45 (43)
C(2’) 9335 (16) 4416 (12) 7487 (7) 5.18 (37)
C(3’) 9253 (17) 5647 (12) 7871 (10) 6.65 (39)
C(4’) 7832 (19) 6309 (10) 7086 (8) 5.30 (43)
Table 6. Fractional coordinates (x 104) for nonhydrogen atoms
in compound III
Ge 4304 (1) 2097 (0) 5970 (0) 3.26
F 5053 (5) 1280 (3) 4386 (2) 5.50
O(1’) 6454 (5) 5417 (3) 6533 (2) 4.70
0(2) 9141 (5) 5177 (3) 5755 (2) 4.16
0(4) 7377 (5) 2155 (3) 3724 (2) 4.85
N(1) 7219 (4) 3742 (3) 5877 (2) 2.98
N(3) 8261 (5) 3648 (4) 4765 (2) 3.53
C(2) 8260 (6) 4255 (4) 5483 (3) 3.33
C(4) 7276 (6) 2634 (4) 4363 (3) 3.64
C(5) 6120 (6) 2249 (4) 4784 (3) 3.81
C(6) 6045 (5) 2751 (3) 5496 (3) 3.10
C(7) 2240 (10) 1296 (8) 5019 (5) 5.57
C(8) 3253 (9) 3367 (6) 6404 (5) 4.65
C(9) 5753 (9) 997 (5) 6912 (4) 4.36
C(1 ’) 7349 (6) 4288 (4) 6714 (3) 3.37
C(2’) 9290 (7) 4449 (6) 7458 (3) 4.44
C(3’) 9163 (11) 5685 (8) 7817 (6) 6.43
C(4’) 7734 (10) 6323 (6) 7029 (5) 5.62
(9)
(10)
(12)
(9)
(lo)
(17)
(19)
(13)
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Lithiation of Ftorafurwas carried out in THF below-70C using 4.2 equiv, of lithium diisopropylamide
(LDA). After 1 h the resulting clear solution of the C-6 lithiated ftorafur was treated with the
corresponding trialkylchlorosilane, -germane or-stannane at -70C:
O O
HN’,F
1. (i-Pr)2NLi HN,F
ONj 2. R3MCl - ONMR3
R3M SiMe3 (I), SiEt3 (11), GeMe3 (111), GeEt3 (IV), SnMe3
After working up of the reaction mixture the first 6-substituted organosilicon, -germanium and -tin
derivatives of uracil have been obtained.
The 6-substituted organosilicon (I) and organogermanium (111) derivatives of ftorafur are isostructu-
ral. The stereoscopic view of the molecule III is given in the Figure 1.
0(4) 0(4)
C(4) F C(4) F
C(2) C(2)
0(2) C(9) 0(2)
CO’) C(8) CO’)
C(2’) C(4’) C(2’)
c(3’) c(3’)
Figure 1. Molecular structure of 1-(2-tetrahydrofuryl)-5-fluoro-6-trimethylgermyluracil III
(stereoscopic view)
The bond lengths and angles in uracil and tetrahydrofuranyl (THF) rings of compounds and III are
in agreement with the values obtained in tetrahydrofuranyluracil (11), 1-(2-tetrahydrofuranyl)- (12,13)
and 1-(5-trifluoromethyl-2-tetrahydrofuranyl)-5-fluorouracils (14). The glycosyl bond length in the
compounds and III is slightly shorter than in structures reported in (11-14) and trends to the average
value of 1.464/, (15).
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Atoms of the uracil ring in molecules of compounds and III deviates from the average plane and
have screw ($2) conformation. Torsional angles (see Table 4) show that the THF rings assume
conformations near twist-envelope conformation with atoms C(3’) and C(4’) out of the )lane of the
three others by-0.32(2) , 0.21(1) ,, for and-0.366(9) ,,, 0.156(8) for III, respectively. The
configuration of the THF ring in both two compounds is C(3’)-exo--C(4’)-endo.
In comparison with closely related compounds (11-14) the main difference found in reported
compounds is the relative orientation of the uracil and five-membered rings. In structures and III
the uracil moiety exhibits a sin orientation with respect to the THF ring, while anti conformation was
found for compounds described in 0-
4).
Possibly this is a result of the influence of the bulky substituent in 5-fluorouracil ring at C(6). The
voluminous SiMe3 and GeMe3 groups make changes in molecular conformations and also in the
bond lengths. Inspection of the bond lengths (’rable 2) indicates that the C(6) Si and C(6) Ge
are significantly longer than Si-C and Ge--C bonds with methyl groups carbon.
Similar to crystal structures described in (12-14) in the crystal structures of and III there were found
hydrogen bonds N(3)-H(3)...0(2) of an intermolecular nature. Distances between N(3) and 0(2) are
2.891 ,, and 2.887 ,, for compounds and III, respectively.
A 90 min long incubation with both germyl derivatives III and IV reduced the 3H-uridine incorpora-
tion rate. Trimethylgermyl derivative (111) caused a two-fold decrease (from 9304.5 +_. 3121.5
dpm//g RNA to 4649 _+ 1068.4 dpm//g RNA), triethylgermyl derivative IV was less effective (to
5433.6 __. 1369.6 dpm//g RNA) (Fig. 2). The compounds manifested a tendency to reduce the
3H-thymidine incorporatiuon, however it was less pronounced and the data were not statistically
significant (16). For example, two-hour incubation with compound IV decreased 3H-thymidine
incorporation from 420.7 __. 130.2 dpm//g DNA to 307.5 +_. 24.75 dpm//g DNA.
3H dmp//g RNA 10-3
10
6
4
2
T
2 3
Figure 2. Effects of compounds III and IV on intensity of 3H-uridine incorporation. 1 control (0.7%
ethanol); 2 150/M III; 3- 150/M IV. Incubation 90 min.
These preliminary results indicate the ability of germanium-modified nucleoside analogues to
interfere with transcription and, possibly, with replication processes. Several hypothetical mechan-
isms of action can be proposed. The substances in question could incorporate in the synthesized
molecules and block polymerase movement or act as enzyme inhibitors. Further studies of
molecular mechanisms of action are necessary for the evaluation of significance of the germanium-
modified compounds as biologically active substances.
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